A. S. M. Giasuddin1,*, K. A. Jhuma2, M. A. M. Choudhury3, A. M. M. Haq4
1Senior Consultant in Laboratory Medicine (Biochemistry & Immunology) and Founder Director, Impulse Hospital, ImHS&RCLtd, 304/E, Tejgaon Industrial Area, Dhaka-1208, Bangladesh.
2Professor of Biochemistry and Head at Dhaka Medical College, Dhaka-1000, Bangladesh.
3Professor of Surgery, Department of Surgery, MCW&H, MHWT, Plot-4, Road-8/9, Sector-1, Uttara Model Town, Dhaka-1230, Bangladesh.
4Honorary Professor of Medicine, Department of Internal Medicine, MCW&H and Chairman of MRU, MCN&H, MHWT, Uttara, Dhaka-1230, Bangladesh.
*Corresponding author: A. S. M. Giasuddin
References
[1] James HG. Kenneth RM, Scot LF. (1996). Current diagnosis and treatment in gastroenterology. (Int. ed) Appletin and Lange, Connecticut, USA.
[2] Batazoo H, Hazra NK. (2013). Analysis of serum lipid profile in Cholilithiasis patients. J Nepal Health Res Counc 11: 53-55.
[3] Rao PJ, Jarari A, El Awami H, Patil TN. (2012). Lipid profile in bile and serum of cholelithiasis patients-A Comparative study. J Basic Med Allied Sci 1: 15-21.
[4] Channa NA. (2008). Gallstone disease: a review. Pak Arm Forces Med J 58: 197-208.
[5] Portincasa P, DiCiaula A, Vendemiale G, Palmieri V, Moschetta A, et al. (2000). Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 30: 317-324.
[6] Malik AA, Wani ML, Tak Sl. Irshad I, Al-Hasan N. (2011). Association of dyslipidaemia with chililithiasis and effect of cholecystectomy on the same. IntSurg 9: 641-642.
[7] Skill NJ, Scott RE, Wu J, Maluffio MA. (2011). Hepatocellular carcinoma associated lipid metabolism reprogrmming. J Surg Res 169: 51-56.
[8] Hasegawa T. Makino I. (1995). Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder of patients with gallstones. J Gastroenterol 30: 96-102.
[9] Juvonen T. Kervinen K, Kairaluoma MI, Kesaniemi YA. (1995). Effect of cholecystectomy on plasma lipid and lipoprotein levels. Hepatogastroenterology 42: 377-382.
[10] Pinheiro-Junior S, Pinhel MA, Nakazone MA, Pinheiro A, Amorim GF, et al. (2012). Effect of genetic variants related to lipid metabolism as rsk factors for cholilithiasis after bariatric surgery in Brazilian population. Obes Surg 22: 623-633.
[11] Everhart JE, Khare M, Hill M, Maurer KR. (1999). Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 117: 632-639.
[12] Amigo L, Zanlungo S, Mendoza H, Miquel JF, Nervi F. (1999). Risk factors and pathogenesis of cholesterol gallstones: state of the Art (Editorial). Eur Rev Med Pharmacol Sci 3: 241-246.
[13] Avunduk C. (2008). Gallstones. In: Manual of Gastroenterology: Diagnosis and Therapy, Fourth Edition; London: Lippincott Wiliams & Wilkins.
[14] Smith BF. (1987). Human gallbladder mucin binds biliary lipids and promotes cholesterol crystal nucleation in model bile. J lipid Res 28: 1088-1097.
[15] Womack NA. (1971). The development of gallstones. Surg Gyn Obstet 133: 937-645.
[16] Smith BF, LaMont JT. (1985). Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix: effects of reducing agents on in vitro dissolution of matrix and intact gallstones. J Clin Invest 76: 439-445.
[17] Haq AMM, Giasuddin ASM, Jhuma KA, Choudhury MAM. Effect of cholecystectomy on lipid profile in Bangladeshi patients with cholelithiasis. J MetabSynd 2016; 5(I): 192. doi: 10.4172/2167-0943.100092.
[18] Giasuddin ASM, Jhuma KA, Choudhury MAM, Haq AMM. Lipoprotein (a) status and effect of laparoscopic cholecystectomy on it in Bangladeshi patients with choleclithiasis. J MetabSynd 2016; 5(4): 216. doi: 10.4172/2167-0943.1000216.
[19] Choudhury MAM, Giasuddin ASM, Jhuma KA, Haq AMM. Effects of laporoscopic cholecystectomy on mucin1 and cholesterol ester transfer protein status in Bangladeshi patients with cholelithiasis. J Metab Synd 2018; 7(1): 240. doi: 10.4172/2167-0943.1000240.
[20] Jhuma KA, Giasuddin ASM, Choudhury MAM, Haq AMM. Effects of laparoscopic cholecystectomy on apolipoproteins (ApoA1, ApoB100, ApoE) status in Bangladeshi patients with cholelithiasis. J Clin Lab Med 2018; 3(1): 1-5.
DOI: https://dx.org/10.16966/2578-9578.121.
[21] Giasuddin ASM, Jhuma KA, Choudhury MAM, Haq AMM. Associations among lipoprotein(a) and apoliproproteins (A1, B100, E) status in Bangladeshi patients with cholelithiasis and effects of laparoscopic cholecystectomy on the status. Am JBiomed Sci & Res 2021; 12 (1): 15. AJBSR. MS. ID. 001710. DOI: https://dx.org/10.34297/AJBSR.2021.12.001710.
[22] Giasuddin ASM, Jhuma KA, Choudhury MAM, Haq AMM. Associations among lipid profile, mucin1 and cholesterol ester fransfer protein status in Bangladeshi patients with cholelithiasis and effects of laparoscopic cholecystectomy on them. Int J ClinExp Med Res 2022; 6(4): 330-339. Doi: https://dx.org/10.26855/ijcemr.2022.10.002.
[23] Remaley AT, Rifai N, Wamick GR. (2015). Lipids, lipoproteins, apolipoporteins and other cardic risk factors. In: Burtis CA, Bruns DE, Sawyer BG (Editors) Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics (7th edn.), Elsevier, St Louis, Missouri, USA, pp: 388-411.
[24] Dividson MH, Christine M, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, et al. (2011). Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J ClinLipidol 5(5): 338-367.
DOI: https://dx.org/10.1016/J.Jacl.2011.07.005
[25] Vesper HW, Wilson PW, Rifai N. (2012). A massage from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IV. ClinChem 58: 523-527.
[26] Danesh J. Collins R, Peto R. (2000). Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102: 1082-1085.
[27] Bargash NA, Elewa SM, Hamdi EA, Barghash AA, EI Dine R. (2004). Role of plasma homocysteine and lipoprotein (a) in coronary artery disease. Br J Biomed Sci 61: 78-83.
[28] Giasuddin ASM, Jhuma KA, MujibulHaq AM. (2008). Lipoprotein (a) status in Bangladeshi patients with diabetes mellitus. J Med Coll Women Hosp 6: 74-82.
[29] Mujibul Haq AM, Giasuddin ASM, Huque MM. (2011). Serum total homocysteine and lipoprotein (a) levels in acute myocardial infarction and their response to treatment with vitamins. J CollPhysSurg Pak 21: 266-270.
[30] Eckel PH, Grundy SM, Zimmet PZ. (2005). TheMetab Synd. Lancet 365: 1415-1428.
[31] Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano Rodriguez G, et al. (2005). Metabolic syn-drome as a risk factor for gallstone disease. World J Gastroenterol 11: 1653-1657.
[32] Stinton LM, Shaffer EA. (2012). Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver 6: 172-187.
[33] Petitti DB, Friedman GD, Klatsky AL. (1981). Association of a history of gallbladder disease with a reduced concentration of high density-lipoprotein cholesterol. N Engl J Med 304: 1396-1398.
[34] Ahlberg J. (1979). Serum lipid levels and hyperlipoproteinaemia in gallstone patients. Acta ClinScand 145: 373-377.
[35] Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
[36] Febyan R Cholelithiasis. A brief review on diagnostic approach and management in clinical practice. Adv Res Gastroenterol-Hepatol 2020; 15(2): 5555913. DOI: https://10.19080/ARGAH2020.15.555913.